James Peyer - Net Worth and Insider Trading
James Peyer Net Worth
The estimated net worth of James Peyer is at least $3 Million dollars as of 2024-06-22. James Peyer is the Director, 10% Owner of Sensei Biotherapeutics Inc and owns about 5,231,488 shares of Sensei Biotherapeutics Inc (SNSE) stock worth over $3 Million. Details can be seen in James Peyer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Peyer has not made any transactions after 2022-03-02 and currently still holds the listed stock(s).
Transaction Summary of James Peyer
James Peyer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Peyer owns 1 companies in total, including Sensei Biotherapeutics Inc (SNSE) .
Click here to see the complete history of James Peyer’s form 4 insider trades.
Insider Ownership Summary of James Peyer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNSE | Sensei Biotherapeutics Inc | 2023-07-31 | director & 10 percent owner |
James Peyer Latest Holdings Summary
James Peyer currently owns a total of 1 stock. James Peyer owns 5,231,488 shares of Sensei Biotherapeutics Inc (SNSE) as of March 2, 2022, with a value of $3 Million.
Latest Holdings of James Peyer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNSE | Sensei Biotherapeutics Inc | 2022-03-02 | 5,231,488 | 0.65 | 3,383,203 |
Holding Weightings of James Peyer
James Peyer Form 4 Trading Tracker
According to the SEC Form 4 filings, James Peyer has made a total of 43 transactions in Sensei Biotherapeutics Inc (SNSE) over the past 5 years, including 43 buys and 0 sells. The most-recent trade in Sensei Biotherapeutics Inc is the acquisition of 1,203 shares on March 2, 2022, which cost James Peyer around $3,850.
Insider Trading History of James Peyer
- 1
James Peyer Trading Performance
GuruFocus tracks the stock performance after each of James Peyer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Peyer is -44.63%. GuruFocus also compares James Peyer's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Peyer within 3 months outperforms 0 times out of 43 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Peyer's insider trading performs compared to the benchmark.
Performance of James Peyer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.64 | | | | | |
| Relative Return to S&P 500(%) | -17.12 | | | | | |
James Peyer Ownership Network
James Peyer Owned Company Details
What does Sensei Biotherapeutics Inc do?
Who are the key executives at Sensei Biotherapeutics Inc?
James Peyer is the director & 10 percent owner of Sensei Biotherapeutics Inc. Other key executives at Sensei Biotherapeutics Inc include Chief Business Officer Stephanie Krebs , director & President & CEO John Celebi , and 10 percent owner & other: See Remarks Cambrian Biopharma Inc .
Sensei Biotherapeutics Inc (SNSE) Insider Trades Summary
Over the past 18 months, James Peyer made no insider transaction in Sensei Biotherapeutics Inc (SNSE). Other recent insider transactions involving Sensei Biotherapeutics Inc (SNSE) include a net sale of 3,439,461 shares made by Apeiron Investment Group Ltd. , and a net purchase of 500 shares made by John Celebi .
In summary, during the past 3 months, insiders sold 0 shares of Sensei Biotherapeutics Inc (SNSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,441,661 shares of Sensei Biotherapeutics Inc (SNSE) were sold and 2,700 shares were bought by its insiders, resulting in a net sale of 3,438,961 shares.
Sensei Biotherapeutics Inc (SNSE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sensei Biotherapeutics Inc Insider Transactions
James Peyer Mailing Address
Above is the net worth, insider trading, and ownership report for James Peyer. You might contact James Peyer via mailing address: C/o Sensei Biotherapeutics, Inc., 1405 Research Blvd., Ste. 125, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
